Announce Date | 03/04/2025 |
EPS Normalized Actual | $1.03 (Beat by $0.173) |
EPS GAAP Actual | $1.03 (Beat by $0.173) |
Revenue Actual | $1.05854B |
Revenue Surprise | Beat by $1058.54M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jan 2030 | 8.79 | 43 | 8.48873 | 9.31719 | 1 |
Jan 2029 | 10.67 | 35.43 | 10.44914 | 11.23353 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | -0.37 | -0.37 | 1.05854B | 20.14% | 1058.54M |
FQ4 2024 (Oct 2024) | -0.0685 | -0.0685 | 1.01018B | 22.19% | 1010.18M |
FQ3 2024 (Jul 2024) | 0.19 | 0.19 | 0.963872B | 24.1% | 963.87M |
FQ1 2018 (Jan 2018) | -0.97 | -0.97 | 0.038717B | 100% | 38.72M |
FQ2 2024 (Apr 2024) | 0.18 | 0.18 | 0.921036B | 24.8% | 921.04M |
FQ1 2024 (Jan 2024) | 0.22 | 0.22 | 0.845335B | 24.6% | 845.34M |
FQ4 2023 (Oct 2023) | 0.11 | 0.11 | 0.786014B | 26.1% | 786.01M |
FQ3 2023 (Jul 2023) | 0.04 | 0.04 | 0.731626B | 26.85% | 731.63M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.46837 | -- | 1.4551 | 1.50523 | 29 |
FQ3 2027 (Jul 2027) | 1.4566 | -- | 1.44344 | 1.49316 | 19 |
FQ2 2027 (Apr 2027) | 1.33991 | -- | 1.3278 | 1.37355 | 29 |
FQ1 2027 (Jan 2027) | 1.45523 | -- | 1.43966 | 1.46968 | 12 |
FQ4 2026 (Oct 2026) | 1.57224 | -- | 1.55191 | 1.58482 | 12 |
FQ3 2026 (Jul 2026) | 1.43471 | -- | 1.41616 | 1.44619 | 21 |
FQ2 2026 (Apr 2026) | 1.38222 | -- | 1.36435 | 1.39328 | 12 |
FQ1 2026 (Jan 2026) | 1.36233 | 127.16 | 1.34776 | 1.37585 | 18 |
FQ4 2025 (Oct 2025) | 1.23885 | 105.53 | 1.22283 | 1.24876 | 20 |
FQ3 2025 (Jul 2025) | 1.14689 | 83.43 | 1.13206 | 1.15606 | 13 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.76B | -- | 1.75B | 1.79B | 30 |
FQ3 2027 (Jul 2027) | 1.69B | -- | 1.67B | 1.72B | 20 |
FQ2 2027 (Apr 2027) | 1.61B | -- | 1.6B | 1.65B | 30 |
FQ1 2027 (Jan 2027) | 1.68B | -- | 1.67B | 1.69B | 12 |
FQ4 2026 (Oct 2026) | 1.59B | -- | 1.57B | 1.6B | 12 |
FQ3 2026 (Jul 2026) | 1.51B | -- | 1.49B | 1.52B | 12 |
FQ2 2026 (Apr 2026) | 1.43B | -- | 1.42B | 1.44B | 12 |
FQ1 2026 (Jan 2026) | 1.36B | 22.24 | 1.35B | 1.37B | 12 |
FQ4 2025 (Oct 2025) | 1.26B | 19.88 | 1.25B | 1.27B | 11 |
FQ3 2025 (Jul 2025) | 1.19B | 18.9 | 1.18B | 1.2B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | -0.37 | -0.37 | 100% | |
FQ4 2024 (Oct 2024) | -0.0685 | -0.0685 | 100% | |
FQ3 2024 (Jul 2024) | 0.19 | 0.19 | 100% | |
FQ1 2018 (Jan 2018) | -0.97 | -0.97 | 100% | |
FQ2 2024 (Apr 2024) | 0.18 | 0.18 | 100% | |
FQ1 2024 (Jan 2024) | 0.22 | 0.22 | 100% | |
FQ4 2023 (Oct 2023) | 0.11 | 0.11 | 100% | |
FQ3 2023 (Jul 2023) | 0.04 | 0.04 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $1.06B | $1058.54M | 100% |
FQ4 2024 (Oct 2024) | $0B | $1.01B | $1010.18M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.96B | $963.87M | 100% |
FQ1 2018 (Jan 2018) | $0B | $0.04B | $38.72M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.92B | $921.04M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.85B | $845.34M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.79B | $786.01M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.73B | $731.63M | 100% |